Paper15328151
The use of recombinant factor VIIa in the treatment of bleeding disorders.
Roberts HR and 2 others. Blood, 2004. Cited by 207 papers, by iCite.
Cite this record
ConductScience Library. The use of recombinant factor VIIa in the treatment of bleeding disorders. Papers, record 15328151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15328151
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Coagulation Disorders | Major topic |
| Factor VIIa | Major topic |
| Hemorrhage | Major topic |
| Hemophilia A | |
| Hemophilia B | |
| Humans | |
| Recombinant Proteins | |
| Safety |
Source PubMed
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 207 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41874099 | Inherited Platelet Disorders During Pregnancy and Delivery: Overview of Management Strategies and Emerging Therapeutic Considerations. | Hematol Rep | 2026 | https://conductscience.org/library/papers/41874099 | PubMed |
| 41855508 | Structure of factor VII Gla domain bound to EPCR. | Blood Adv | 2026 | https://conductscience.org/library/papers/41855508 | PubMed |
| 41637560 | Guideline on the emergency management of critical bleeding in patients with immune thrombocytopenia. | Blood Adv | 2026 | https://conductscience.org/library/papers/41637560 | PubMed |
| 40655905 | Life-Threatening Bleeding From Acquired FXI Inhibitors in a Patient With Colorectal Adenocarcinoma. | Case Rep Hematol | 2025 | https://conductscience.org/library/papers/40655905 | PubMed |
| 40218290 | Impact of Drugs Used in Intensive Care on Routine Coagulation Testing. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40218290 | PubMed |
| 39845201 | Persistent Menorrhagia and Hemorrhagic Ovarian Cyst in a Patient With Bernard-Soulier Syndrome: A Case Report. | Cureus | 2024 | https://conductscience.org/library/papers/39845201 | PubMed |
| 39698264 | Advances in Development of Drug Treatment for Hemophilia with Inhibitors. | ACS Pharmacol Transl Sci | 2024 | https://conductscience.org/library/papers/39698264 | PubMed |
| 39515380 | Multidisciplinary Expert Guidance for the Management of Severe Bleeding on Oral Anticoagulation: An Algorithm for Practicing Clinicians. | Thromb Haemost | 2025 | https://conductscience.org/library/papers/39515380 | PubMed |
| 39127325 | Coagulation protease-induced extracellular vesicles: their potential effects on coagulation and inflammation. | J Thromb Haemost | 2024 | https://conductscience.org/library/papers/39127325 | PubMed |
| 38680864 | Intrapulmonary administration of recombinant activated factor VII in pediatric, adolescent, and young adult oncology and hematopoietic cell transplant patients with pulmonary hemorrhage. | Front Oncol | 2024 | https://conductscience.org/library/papers/38680864 | PubMed |
| 38445123 | Perioperative Management of a Frail Patient With Bernard-Soulier Syndrome. | Cureus | 2024 | https://conductscience.org/library/papers/38445123 | PubMed |
| 38039512 | CT-001, a novel fast-clearing factor VIIa, enhanced the hemostatic activity in postpartum samples. | Blood Adv | 2024 | https://conductscience.org/library/papers/38039512 | PubMed |
| 37602759 | KGML-xDTD: a knowledge graph-based machine learning framework for drug treatment prediction and mechanism description. | Gigascience | 2022 | https://conductscience.org/library/papers/37602759 | PubMed |
| 36862401 | Perioperative Considerations in Management of the Severely Bleeding Coagulopathic Patient. | Anesthesiology | 2023 | https://conductscience.org/library/papers/36862401 | PubMed |
| 36254255 | Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms. | Res Pract Thromb Haemost | 2022 | https://conductscience.org/library/papers/36254255 | PubMed |
| 35399372 | Engineered Molecular Therapeutics Targeting Fibrin and the Coagulation System: a Biophysical Perspective. | Biophys Rev | 2022 | https://conductscience.org/library/papers/35399372 | PubMed |
| 35262754 | The neurosurgical management of Severe Hemophilia A and Moyamoya (SHAM): challenges, strategies, and literature review. | Childs Nerv Syst | 2022 | https://conductscience.org/library/papers/35262754 | PubMed |
| 34659753 | Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia. | Clin Case Rep | 2021 | https://conductscience.org/library/papers/34659753 | PubMed |
| 33979970 | [Chinese expert consensus on the management of hemorrhagic complications after hematopoietic stem cell transplantation(2021)]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | https://conductscience.org/library/papers/33979970 | PubMed |
| 33239717 | A critical role of endothelial cell protein C receptor in the intestinal homeostasis in experimental colitis. | Sci Rep | 2020 | https://conductscience.org/library/papers/33239717 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| F9 | 2158 | PubTator's text mining | https://conductscience.org/library/genes/2158 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15328151
GET https://conductscience.org/api/papers/v1/15328151/cited_by?page=2